Key statistics
On Wednesday, HUTCHMED (China) Ltd (H7T1:FRA) closed at 13.50, 29.81% above the 52 week low of 10.40 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.50 |
---|---|
High | 13.50 |
Low | 13.50 |
Bid | 13.80 |
Offer | 14.00 |
Previous close | 13.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 174.42m |
Free float | 88.83m |
P/E (TTM) | 73.70 |
Market cap | 2.75bn USD |
EPS (TTM) | 0.2162 USD |
Data delayed at least 15 minutes, as of Jul 09 2025 07:03 BST.
More ▼
- HUTCHMED to Announce 2025 Half-Year Results
- HUTCHMED to Announce 2025 Half-Year Financial Results
- Update on Joint Corporate Brokers in London
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
More ▼